Ledger.Open graph →
SEC Form D · filed September 26, 2013

EYEGATE PHARMACEUTICALS INC

Offering
$1.4M
Sold
$969K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Thomas E. Hancock · Quincy, MADirectorStephen From · Waltham, MAExec · DirectorPaul Chaney · Melville, NYDirectorThomas Balland · Paris, I0DirectorEric S. Fenster · Kensington, CADirectorMarc Franzman · Milford, CTDirectorFrancis Sapienza · Dallas, TXExec · DirectorLeslie Deshazer · Dallas, TXDirectorMorton Goldberg · Waltham, MADirectorPraveen Tyle · Waltham, MADirectorBernard Malfroy-Camine · Arlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗